Similarly, early-stage (stage I + II) HCC patients with higher ELF3 expression had worse OS (p = 0.016) (Fig. 1g) and DFS (p = 0.034) (Fig. 1h). This evidence concerns the gene ELF3 and hepatocellular carcinoma.